Amgen names CEO chairman, makes other board moves

Published



THOUSAND OAKS, Calif. (AP) — Amgen Inc.’s new CEO will soon take on a second post, as chairman of the board of the world’s largest biotech company.

The company, based in Thousand Oaks, Calif., announced late Thursday that Chief Executive Robert A. Bradway will also become chairman as of Jan. 1. As planned, Bradway will succeed his predecessor as CEO and chairman, Kevin Sharer, who is retiring on Dec. 31.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.